OrbiMed’s Teladoc Health TDOC Stock Holding History

OrbiMed’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-110,000	Closed	-$2.04M	–	132
2023 Q3	$2.04M	Buy	+110,000	New	+$2.57M	0.04%	111

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OrbiMed's TDOC Position: Q4 2023 in Review

OrbiMed sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 110,000 shares — an estimated $2.04M sold.

OrbiMed first reported a position in TDOC in Q3 2023 and held it in 1 quarter. The position peaked at $2.04M in Q3 2023. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

OrbiMed reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
OrbiMed sold 110,000 Teladoc Health shares in Q4 2023, an estimated $2.04M.
OrbiMed first reported a position in Teladoc Health in Q3 2023 and held it in 1 quarter.
OrbiMed's Teladoc Health position peaked at $2.04M in Q3 2023.
435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on OrbiMed's 13F filing for Q4 2023, filed 14 Feb 2024.